Atazanavir inhibits P-glycoprotein and multidrug resistance-associated protein efflux activity.
Lucia
Mothanje Barbara
MB
Golotta
Caterina
C
Rutella
Sergio
S
Rastrelli
Elena
E
Savarino
Andrea
A
Cauda
Roberto
R
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors*; D000069446:Atazanavir Sulfate; D002478:Cells, Cultured; D004347:Drug Interactions; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000378:metabolism; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000037:antagonists & inhibitors*; D009842:Oligopeptides / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000069446:Atazanavir Sulfate; D017320:HIV Protease Inhibitors; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009842:Oligopeptides; D011725:Pyridines